Skip to main content
AkademIndex

Products

For developers

AkademBaseOpen API for the ecosystem
← Back to work

Works cited by this work

28 works

Work: Modeling an active conformation for linear peptides and design of a competitive inhibitor for HMG‐CoA reductase

  1. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

    Marion M. Bradford

    Article197659 citations
    ABI

  2. A Rapid and Sensitive Method for the Quantitation of Microgram Quantities of Protein Utilizing the Principle of Protein-Dye Binding

    Mark A. Bradford

    Article197640 citations
    ABI

  3. Development and use of quantum mechanical molecular models. 76. AM1: a new general purpose quantum mechanical molecular model

    Michael J. S. Dewar, Eve G. Zoebisch, Eamonn F. Healy +1

    Article198517 citations
    ABI

  4. Isolation and Identification of Peptides from Soy 11S-Globulin with Hypocholesterolemic Activity

    Valeriy V. Pak, Minseon Koo, T. D. Kasymova +1

    ArticleProtein Hydrolysis and Bioactive PeptidesChemistry of Natural Compounds200514 citations
    ABI

  5. Statin inhibition of HMG-CoA reductase: a 3-dimensional view

    Eva S. Istvan

    Review article200313 citations
    ABI

  6. Structure—Activity Relationships of the Peptide Ile-Ala-Val-Pro and Its Derivatives Revealed Using the Semi-Empirical AM1 Method

    Valeriy V. Pak, Minseon Koo, N. Lee +2

    Article200512 citations
    ABI

  7. Amino Acid Substitution of Hypocholesterolemic Peptide Originated from Glycinin Hydrolyzate

    Dae Young Kwon, Si Won Oh, Ji Soo Lee +5

    Article200211 citations
    ABI

  8. Conformation Analysis of Ile-Ala-Val-Pro Peptide and Its Derivatives by Circular Dichroism

    Valeriy V. Pak, Minseon Koo, Dae Young Kwon +1

    ArticleChemical Synthesis and AnalysisChemistry of Natural Compounds200411 citations
    ABI

  9. Advances and Continuing Challenges in Achieving Realistic and Predictive Simulations of the Properties of Organic and Biological Molecules

    Peter A. Kollman

    Article199611 citations
    ABI

  10. Peptide design of a competitive inhibitor for HMG‐CoA reductase based on statin structure

    Valeriy V. Pak, Sung Hee Kim, Minseon Koo +3

    ArticleComputational Drug Discovery MethodsBiopolymers200610 citations
    ABI

  11. Geometric versus topological clustering: An insight into conformation mapping

    Oren M. Becker

    Article19979 citations
    ABI

  12. Conformer Profiles and Biological Activities of Peptides

    J. W. Payne, N. Justin Marshall, Barry M. Grail +1

    Article20028 citations
    ABI

  13. Protein secondary structure and circular dichroism: A practical guide

    W. Curtis Johnson

    Review article19908 citations
    ABI

  14. Recognized sequence and conformation in design of linear peptides as a competitive inhibitor for HMG‐CoA reductase

    Valeriy V. Pak, Minseon Koo, L. M. Yun +1

    ArticleComputational Drug Discovery MethodsJournal of Molecular Recognition20078 citations
    ABI

  15. Cholesterol Lowering With Statin Drugs, Risk of Stroke, and Total Mortality

    Patricia R. Hebert

    Article19977 citations
    ABI

  16. HBTU activation for automated Fmoc solid-phase peptide synthesis.

    Cynthia G. Fields, Donna Lloyd, Robyn L. Macdonald +2

    Article19926 citations
    ABI

  17. Flexibility, Conformation Spaces, and Bioactivity

    Oren M. Becker, Yaakov Levy, Orr Ravitz

    Article20006 citations
    ABI

  18. Correcting the Circular Dichroism Spectra of Peptides for Contributions of Absorbing Side Chains

    Chartchai Krittanai, W. Curtis Johnson

    Article19976 citations
    ABI

  19. Conformational interconversions in peptide β-turns: analysis of turns in proteins and computational estimates of barriers 1 1Edited by J. Thornton

    Kannan Gunasekaran, L. Gomathi, C. Ramakrishnan +2

    Article19986 citations
    ABI

  20. The discovery and development of HMG-CoA reductase inhibitors.

    Akira Endo

    Article19926 citations
    ABI

  21. Cholesterol Lowering in the Management of Coronary Artery Disease: The Clinical Implications of Recent Trials

    Daniel A. Eisenberg

    Review article19986 citations
    ABI

  22. Binding effect and design of a competitive inhibitory peptide for HMG-CoA reductase through modeling of an active peptide backbone

    Valeriy V. Pak, Minseon Koo, Min Jung Kim +2

    ArticleComputational Drug Discovery MethodsBioorganic & Medicinal Chemistry20076 citations
    ABI

  23. Structural Mechanism for Statin Inhibition of HMG-CoA Reductase

    Eva S. Istvan, J. Deisenhofer

    Article20016 citations
    ABI

  24. 9-Fluorenylmethoxycarbonyl amino-protecting group

    Louis A. Carpino, Grace Han

    Article19725 citations
    ABI

  25. SOLID‐PHASE PEPTIDE SYNTHESIS USING MILD BASE CLEAVAGE OF <i>N</i><sub>α</sub>FLUORENYLMETHYLOXYCARBONYLAMINO ACIDS, EXEMPLIFIED BY A SYNTHESIS OF DIHYDROSOMATOSTATIN

    Chi‐Deu Chang, Johannes Meienhofer

    Article19784 citations
    ABI